T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Soft-tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Neeta Somaiah, MBBS) · nsomaiah@mdanderson.org · 713-792-3626
Contact: Principal Investigator (Neeta Somaiah, MBBS)

Study leads

Neeta Somaiah, MBBS
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Metastatic Soft-tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1

St Louis, United States

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Solid Tumours · Sarcoma · HNSCC

Abroad (travel likely)RecruitingPHASE1

Beverly Hills, United States · Santa Monica, United States

A Study of CRD3874-SI in People With Solid Tumors

Sarcoma · Merkel Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Advanced Melanoma · Melanoma Metastatic · Sarcoma

Abroad (travel likely)RecruitingPHASE1

Lausanne, Switzerland · Lausanne, Switzerland